💰NIH Notice of Upcoming Closed Meetings for Grant Applications
The National Institutes of Health (NIH) has announced closed meetings of the Center for Scientific Review to evaluate grant applications. These meetings will discuss various scientific research areas and are crucial for businesses seeking federal funding opportunities in health and medical imaging.
Learn More📅Notice of NIH Advisory Council Meeting on Grant Applications
The notice announces a closed meeting of the National Center for Advancing Translational Sciences Advisory Council, focusing on the review of grant applications. It includes information on how interested parties can submit comments and access further details about the agenda and meeting location.
Learn More💰NIH Notice on Closed Meetings for Drug Abuse Grant Applications
The Department of Health and Human Services announces closed meetings by the National Institute on Drug Abuse to review grant applications. This notice ensures confidentiality on sensitive discussions pertaining to trade secrets and personal information, emphasizing the importance of privacy in the evaluation process for potential funding in drug abuse research initiatives.
Learn More💰National Institute on Drug Abuse Grant Evaluation Meetings Notice
The Department of Health and Human Services announces closed meetings for the National Institute on Drug Abuse’s Special Emphasis Panel, focusing on the review of grant applications related to research mitigating the overdose crisis. Meetings will be held virtually to assess various proposal evaluations.
Learn More🏥NIH Notice
The Department of Health and Human Services announces a closed meeting of the Eunice Kennedy Shriver National Institute of Child Health and Human Development’s Special Emphasis Panel to review grant applications. This session emphasizes confidentiality around discussions potentially involving sensitive trade secrets and personal information, marking a significant process in health research funding.
Learn More🧠NIH Announces Closed Meetings for Grant Application Reviews
The document announces closed meetings by the National Institute of Neurological Disorders and Stroke to review grant applications related to neuroscience and pain research. These meetings are designed to evaluate confidential proposals and will not be open to the public, emphasizing the sensitive nature of the discussions regarding potential funding in the field.
Learn More🏥Notice of Closed Meetings by National Heart, Lung, and Blood Institute
This document provides notice of closed meetings held by the National Heart, Lung, and Blood Institute under the Federal Advisory Committee Act. The meetings will focus on reviewing and evaluating contract proposals related to health and research, ensuring discussions remain confidential. The notice includes details on meeting times, contact information, and the significance of trade secrets involved.
Learn More🩺NIH Notice of Closed Meeting on Grant Applications Review
The Department of Health and Human Services announces a closed meeting of the National Institute of Diabetes and Digestive and Kidney Diseases to review grant applications. The meeting will evaluate proposals related to diabetes, digestive diseases, and kidney diseases. The discussions are expected to involve confidential information, emphasizing the need for privacy and protection of intellectual property.
Learn More💰NIH Closed Meetings for Grant Application Review Notice
The National Institutes of Health issues a notice of closed meetings aimed at reviewing and evaluating grant applications related to significant health and scientific research. The meetings, occurring virtually, involve various specialized panels assessing proposals in areas such as hypertension and biochemistry, highlighting the importance of confidential information and potential funding for researchers and institutions.
Learn More💊Implications of New Nonprescription Drug Regulations for Businesses
In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) was delayed until March 21, 2025. Additional time is needed for review; therefore, the delay is extended for an additional 60 days.
Learn More